Enveda Biosciences raises $311M to advance AI-designed drugs for immune diseases and obesity
Enveda Biosciences secures $311M in Series E funding to progress its AI-designed drug pipeline, including treatments for eczema and obesity.
AI drug discovery
Latest AI drug discovery coverage.
Anthropic's $400M biotech buyout fuels AI drug discovery push
Anthropic acquires Coefficient Bio for $400M, partnering with Novo Nordisk and Bristol Myers Squibb to accelerate AI-driven drug discovery.
Phoenix Lab's $8M seed round led by Menlo Ventures, backed by ex-Apple AI chief
Phoenix Lab, an AI drug discovery startup, raises $8M in seed funding led by Menlo Ventures, with ex-Apple AI chief John Giannandrea among investors.